Jing Zhou
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$12.6MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $12.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 15, 2021 | NIH | SBIR Phase II A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies | $1.2M | ISOPLEXIS CORPORATION |
| Jun 25, 2020 | NIH | SBIR Phase II Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance | $961K | ISOPLEXIS CORPORATION |
| Apr 28, 2020 | NIH | SBIR Phase II A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies | $1.2M | ISOPLEXIS CORPORATION |
| Jul 18, 2019 | NIH | SBIR Phase II Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance | $999K | ISOPLEXIS CORPORATION |
| Jun 17, 2019 | NIH | SBIR Phase II A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies | $1.7M | ISOPLEXIS CORPORATION |
| Jun 17, 2019 | NIH | SBIR Phase II A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies | $4.0M | ISOPLEXIS CORPORATION |
| Sep 12, 2018 | NIH | SBIR Phase II Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance | $225K | ISOPLEXIS CORPORATION |
| Mar 26, 2018 | NIH | SBIR Phase II Precision quality check of immunotherapeutics via single-cell cytokine mapping | $910K | ISOPLEXIS CORPORATION |
| Jun 29, 2017 | NIH | SBIR Phase II Precision quality check of immunotherapeutics via single-cell cytokine mapping | $974K | ISOPLEXIS CORPORATION |
| Jun 9, 2017 | NIH | SBIR Phase I Developing an integrated sorting and single cell analysis tool for the analysis of rare T Cells subsets in Autoimmunity | $163K | ISOPLEXIS CORPORATION |
| Sep 21, 2016 | NIH | SBIR Phase I Precision Quality Check of Immunotherapeutics via Single Cell Cytokine Mapping | $160K | ISOPLEXIS CORPORATION |
| Sep 21, 2016 | NIH | SBIR Phase I Precision Quality Check of Immunotherapeutics via Single Cell Cytokine Mapping | $160K | ISOPLEXIS CORPORATION |
Peer ranks
Federal funding#40
Awards as PI#97
Patents#505
Companies
- ISOPLEXIS CORPORATIONLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.